Analyst Concall
Persistent Systems confident of gaining market share
This story was originally published at 20:21 IST on 21 April 2026
Register to read our real-time news.Informist, Tuesday, Apr. 21, 2026
Please click here to read all liners published on this story
--Persistent Systems: AI agent portfolio over 500, includes Google, Microsoft
--CONTEXT: Persistent Systems mgmt comments in post-earnings analyst concall
--Persistent Systems: Working with leading pharma co on diabetes
--Persistent Systems: Working with leading pharma co on metabolic disorders
--Persistent Systems: Not directly affected by West Asia situation
--Persistent Systems: Cautiously optimistic; will continue to gain mkt share
--Persistent Systems: Slow growth in India ops an aberration
--Persistent Systems: Growth, investment priority to improve margins
--Persistent Systems: See growth being led by healthcare, BFSI ops
By Ashutosh Pati and Shweta
MUMBAI – Persistent Systems Ltd. has not been directly affected by the war in West Asia, the mid-cap information technology major's management told analysts in the post-earnings conference call Tuesday. While high oil prices remain a concern for the whole sector, the company remains "cautiously optimistic" and is confident of gaining market share in the coming quarters.
"...we have zero to very little exposure in Middle East (West Asia) but as far as the bigger thing is concerned, if it goes on for more time then obviously you know it is an issue because oil prices remaining higher for long will have an impact on the inflation etc but that will affect the entire sector not just us...," the management said.
Persistent Systems sees growth in the coming quarters to be led by its healthcare and life sciences and banking, financial services, and insurance segments. The company aims to keep its earnings before interest and taxes margin in 16-17% range but with the current macroeconomic environment, its main priorities are "growth...investing back into business and developing capabilities that's more important" the management said.
The management termed the growth in the company's India business an "aberration" due to a renewal that was done in rupee terms in an erstwhile business. They expect this to normalise from the next quarter. However, its business in Europe saw a decline and the company wants to focus more on it. Persistent Systems continues to spend on its AI infrastructure as it has upgraded the GenAI Hub and Agent Studio with more runtime, orchestration, evaluation, and knowledge management abilities.
The company's AI porfolio has exceeded 500 agents built in-house and across partnered ecosystems, which include Google, Microsoft, Salesforce, and Nvidia. It is currently working with a leading pharmaceutical company focused on diabetes and metabolic disorder. "We are helping them tackle a core challenge in early-stage drug discovery on how to unify fragmented clinical and research data and make it into actionable using AI," the management said.
The company reported a consolidated net profit of INR 5.29 billion for the March quarter, up over 20% sequentially. Its revenue rose over 7% sequentially to INR 40.56 billion. The company declared its results post market hours. Tuesday, shares of the company closed a tad higher at INR 5,329.90 on the National Stock Exchange. End
Edited by Akul Nishant Akhoury
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
Share this Story:
